356 related articles for article (PubMed ID: 30117050)
41. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
Brizendine KD; Richter SS; Cober ED; van Duin D
Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
[TBL] [Abstract][Full Text] [Related]
42. Emerging clinical role of pivmecillinam in the treatment of urinary tract infections caused by Extended Spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
Raja NS
Int J Clin Pract; 2019 Sep; 73(9):1-5. PubMed ID: 31243859
[TBL] [Abstract][Full Text] [Related]
43. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471
[TBL] [Abstract][Full Text] [Related]
44. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County.
Lindbäck H; Lindbäck J; Sylvan S; Melhus A
Scand J Infect Dis; 2010 Apr; 42(4):243-8. PubMed ID: 20085420
[TBL] [Abstract][Full Text] [Related]
45. Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.
Yang YS; Ku CH; Lin JC; Shang ST; Chiu CH; Yeh KM; Lin CC; Chang FY
J Microbiol Immunol Infect; 2010 Jun; 43(3):194-9. PubMed ID: 21291846
[TBL] [Abstract][Full Text] [Related]
46. A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines.
Vanstokstraeten R; Belasri N; Demuyser T; Crombé F; Barbé K; Piérard D
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2371-2377. PubMed ID: 34175999
[TBL] [Abstract][Full Text] [Related]
47. Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
Uyar Aksu N; Ekinci Z; Dündar D; Baydemir C
Pediatr Int; 2017 Feb; 59(2):176-180. PubMed ID: 27501161
[TBL] [Abstract][Full Text] [Related]
48. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
[No Abstract] [Full Text] [Related]
49. Relationship between phylogenetic groups, antibiotic resistance and patient characteristics in terms of adhesin genes in cystitis and pyelonephritis isolates of Escherichia coli.
Er DK; Dundar D; Uzuner H; Osmani A
Microb Pathog; 2015 Dec; 89():188-94. PubMed ID: 26518125
[TBL] [Abstract][Full Text] [Related]
50. Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Ipekci T; Seyman D; Berk H; Celik O
J Infect Chemother; 2014 Dec; 20(12):762-7. PubMed ID: 25179392
[TBL] [Abstract][Full Text] [Related]
51. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
[TBL] [Abstract][Full Text] [Related]
52. Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of
Karlowsky JA; Wise MG; Hackel MA; Pevear DC; Moeck G; Sahm DF
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0093422. PubMed ID: 36286518
[TBL] [Abstract][Full Text] [Related]
53.
Abdelraouf K; Stainton SM; Nicolau DP
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061165
[TBL] [Abstract][Full Text] [Related]
54. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
[TBL] [Abstract][Full Text] [Related]
55. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.
Kresken M; Pfeifer Y; Hafner D; Wresch R; Körber-Irrgang B;
Int J Antimicrob Agents; 2014 Oct; 44(4):295-300. PubMed ID: 25223936
[TBL] [Abstract][Full Text] [Related]
56. Antimicrobial Resistance in Bacteria Causing Urinary Tract Infections.
Salh KK
Comb Chem High Throughput Screen; 2022; 25(7):1219-1229. PubMed ID: 34161207
[TBL] [Abstract][Full Text] [Related]
57. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
58. Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Thelen H; Dilworth TJ; Mercier RC
Chemotherapy; 2022; 67(4):261-268. PubMed ID: 36417841
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
Abe Y; Inan-Erdogan I; Fukuchi K; Wakabayashi H; Ogawa Y; Hibino S; Sakurai S; Matsuhashi K; Watanabe Y; Hashimoto K; Ugajin K; Itabashi K
J Infect Chemother; 2017 Aug; 23(8):517-522. PubMed ID: 28528936
[TBL] [Abstract][Full Text] [Related]
60. Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E coli from Trinidad and Tobago.
Akpaka PE; Legall B; Padman J
West Indian Med J; 2010 Dec; 59(6):591-6. PubMed ID: 21702229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
